Literature DB >> 27144625

Functional Esophageal Disorders.

Qasim Aziz1, Ronnie Fass2, C Prakash Gyawali3, Hiroto Miwa4, John E Pandolfino5, Frank Zerbib6.   

Abstract

Functional esophageal disorders consist of a disease category that present with esophageal symptoms (heartburn, chest pain, dysphagia, globus) not explained by mechanical obstruction (stricture, tumor, eosinophilic esophagitis), major motor disorders (achalasia, EGJ outflow obstruction, absent contractility, distal esophageal spasm, jackhammer esophagus), or gastroesophageal reflux disease (GERD). While mechanisms responsible are unclear, it is theorized that visceral hypersensitivity and hypervigilance play an important role in symptom generation, in the context of normal or borderline function. Treatments directed at improving borderline motor dysfunction or reducing reflux burden to sub-normal levels have limited success in symptom improvement. In contrast, strategies focused on modulating peripheral triggering and central perception are mechanistically viable and clinically meaningful. However, outcome data from these treatment options are limited. Future research needs to focus on understanding mechanisms underlying visceral hypersensitivity and hypervigilance so that appropriate targets and therapies can be developed.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Rome IV; chest pain; dysphagia; esophageal motility disorders; gastroesophageal reflux disease; globus; heartburn

Year:  2016        PMID: 27144625     DOI: 10.1053/j.gastro.2016.02.012

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  52 in total

Review 1.  The Proton Pump Inhibitor Nonresponder: a Behavioral Approach to Improvement and Wellness.

Authors:  Megan E Riehl; Joan W Chen
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

Review 2.  Overlap Between GERD and Functional Esophageal Disorders-a Pivotal Mechanism for Treatment Failure.

Authors:  Ofer Z Fass; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2019-03

Review 3.  Globus pharyngeus: a review of etiology, diagnostics, and treatment.

Authors:  Pia Järvenpää; Perttu Arkkila; Leena-Maija Aaltonen
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-25       Impact factor: 2.503

4.  [Gastroenterological diseases as triggers of chest pain].

Authors:  J Labenz; C Labenz
Journal:  Internist (Berl)       Date:  2017-01       Impact factor: 0.743

Review 5.  How to Diagnose and Treat Functional Chest Pain.

Authors:  Jose M Remes-Troche
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

6.  Minor psychiatric disorders and objective diagnosis of gastroesophageal reflux disease.

Authors:  Rafael Melillo Laurino Neto; Fernando A M Herbella; Andre Zugman; Vic Velanovich; Beth Montera; Francisco Schlottmann; Marco G Patti
Journal:  Surg Endosc       Date:  2019-02-27       Impact factor: 4.584

Review 7.  Refractory Heartburn: A Challenging Problem in Clinical Practice.

Authors:  Gerson Domingues; Joaquim Prado P Moraes-Filho; Ronnie Fass
Journal:  Dig Dis Sci       Date:  2018-01-20       Impact factor: 3.199

Review 8.  Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.

Authors:  Marzio Frazzoni; Nicola de Bortoli; Leonardo Frazzoni; Salvatore Tolone; Vincenzo Savarino; Edoardo Savarino
Journal:  Dig Dis Sci       Date:  2017-05-26       Impact factor: 3.199

Review 9.  Comparative Efficacy of Antidepressants for Symptoms Remission of Gastroesophageal Reflux: A Bayesian Network Meta-analysis of Randomized Controlled Trials.

Authors:  Xiao-Bei Si; Lin-Yu Huo; De-Ying Bi; Yu Lan; Shuo Zhang
Journal:  Turk J Gastroenterol       Date:  2021-10       Impact factor: 1.852

10.  Habitual Green Kiwifruit Consumption Is Associated with a Reduction in Upper Gastrointestinal Symptoms: A Systematic Scoping Review.

Authors:  Simone B Bayer; Chris M Frampton; Richard B Gearry; Giovanni Barbara
Journal:  Adv Nutr       Date:  2022-06-01       Impact factor: 11.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.